Medibank share price resilient as class action law suit hits

The Medibank share price has managed a positive move this morning despite news on legal action regarding the October data breach.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price has moved back into positive territory in morning trade
  • The ASX 200 health insurer is facing a class action lawsuit in relation to October's massive data breach
  • Law firm Maurice Blackburn has lodged a representative complaint with the Office of the Australian Information Commission

The Medibank Private Ltd (ASX: MPL) share price is edging higher in morning trade, up 0.8% after opening 0.2% lower.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock, Australia's largest health insurer, closed yesterday trading for $2.97. Medibank shares are currently trading for $3 apiece.

While that's no huge lift, the Medibank share price has managed a positive move this morning. That's despite what looks to be the commencement of a class action lawsuit in regard to the massive 12 October data breach.

A boy stands in still ankle-deep water brandishing a bow and arrow.

Image source: Getty Images

As a quick recap, in October Russian-linked cybercriminals accessed the names, dates of birth, addresses, phone numbers and email addresses of 9.7 million current and former Medibank customers. They also hacked into the health claims data for some 480,000 customers.

The Medibank share price fell more than 20% over the following weeks in the wake of the cyberattack. The health insurer did not pay the ransom demands, and much of the stolen data was published on the dark web.

This morning the company reported that class action lawyers from Maurice Blackburn have lodged a representative complaint with the Office of the Australian Information Commission (OAIC).

Medibank said that the OAIC has not yet been in contact about the complaint.

"The complaint includes allegations that Medibank has breached the Australian Privacy Principles and seeks compensation for individuals whose personal information was exposed as a consequence of the cybercrime," the health insurer stated.

Medibank said it will continue to support its customers with the impact of the cybercrime through its previously announced Cyber Response Support Program. That program includes "mental health and wellbeing support, identity protection and financial hardship measures".

The company also reiterated that it will continue to cooperate with the OAIC in this ongoing investigation.

Medibank share price snapshot

The Medibank share price remains down 15% since October's massive data breach was revealed. As you can see in the chart below, shares are now down 13% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Six smiling health workers pose for a selfie.
Healthcare Shares

4DMedical share price rises as FY26 revenue climbs, losses moderate

4DMedical lifted revenue 21% and improved its adjusted net loss for FY26, while investing in new AI-driven medical imaging solutions.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab

Imricor Medical Systems has teamed up with Philips to launch a new MR-guided cardiac interventions lab, targeting broader clinical adoption.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Why now is the time to buy low on these ASX healthcare shares with up to 84% upside

These two stocks have big upside.

Read more »

Silver dice with buy and sell written on them on top of stock market charts.
Healthcare Shares

CSL shares have surged 49%: Are brokers finally turning bullish?

CSL’s recovery is gathering pace, but has the share price already priced in the turnaround?

Read more »

a doctor wearing a white coat with a stethoscope around her neck stares out a window with her hand to the side of her face as though in deep thought.
Healthcare Shares

Clarity Pharmaceuticals FY26 earnings: Revenue jumps, losses widen as clinical pipeline progresses

Clarity Pharmaceuticals reported strong FY26 revenue growth, a wider loss, and progress towards commercialisation of its radiopharmaceutical pipeline.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Healthcare Shares

Clinuvel Pharmaceuticals posts 10th consecutive profit and maintains dividend

Clinuvel Pharmaceuticals reported its tenth straight profit, rising cash reserves, and steady dividend for FY2026.

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Healthcare Shares

Should I buy CSL shares before the end of August?

I think the company's earnings outlook is starting to look more encouraging.

Read more »

Female pharmacist smiles with a digital tablet.
Earnings Results

Sigma Healthcare FY26 earnings: Record profit as Chemist Warehouse merger delivers growth

The company reported double-digit revenue growth.

Read more »